Managing chronic obstructive pulmonary disease in primary health care: the impact of pulmonary rehabilitation

Autores

  • Dr. Guilherme Oliveira Médico Interno de Medicina Geral e Familiar. USF Esgueira +, ACeS Baixo Vouga. Aveiro, Portugal. https://orcid.org/0000-0003-0744-4686
  • Dr.ª Rita Félix Médica Interna de Medicina Geral e Familiar. USF Fénix de Aveiro, ACeS Baixo Vouga. Aveiro, Portugal.
  • Dr. Pedro Ruivo dos Santos Médico Interno de Medicina Geral e Familiar. USF Santa Joana, ACeS Baixo Vouga. Aveiro, Portugal. https://orcid.org/0009-0005-3355-3108
  • Dr. Luís Monteiro Assistente Graduado de Medicina Geral e Familiar. USF Esgueira +, ACeS Baixo Vouga. Aveiro, Portugal | CINTESIS – Centre for Health Technology and Services Research, Faculdade de Medicina, Universidade do Porto. Porto, Portugal | Department of Medical Sciences, University of Aveiro. Aveiro, Portugal.
  • Dr.ª Cristina Tejo Assistente Graduada de Medicina Geral e Familiar. USF Esgueira +, ACeS Baixo Vouga. Aveiro, Portugal.

DOI:

https://doi.org/10.32385/rpmgf.v40i1.13749

Palavras-chave:

Chronic obstructive pulmonary disease, Rehabilitation, Primary health care, Quality of life

Resumo

Introduction: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, and its management involves improving quality of life, delaying progression, and minimizing exacerbations. The benefit of pulmonary rehabilitation in COPD has been documented in the literature. This intervention can be applied to a primary healthcare setting, using community resources. 

Objectives: This systematic review sought to compile current evidence implying the impact of pulmonary rehabilitation in a primary healthcare setting on the quality of life of patients with COPD.

Methods: Three databases were searched for randomized controlled trials. We included community-based pulmonary rehabilitation and excluded interventions in a hospital setting. The primary outcome was health-related quality of life; secondary outcomes were functional exercise capacity and mortality. Data extraction and triage were performed independently by three authors, and bias was evaluated using the Cochrane Risk of Bias Tool.

Results: Four studies met the search criteria. Three studies reported benefits in at least one of the outcomes; a fourth reported no differences between groups. Rehabilitation frequency and duration seemed to have some impact on all outcomes. Mortality was higher in the control groups when available. The included studies had important limitations, namely the inability to blind interventions.

Conclusions: Pulmonary rehabilitation in a primary health care setting benefits the quality of life and functional exercise capacity in COPD patients. Optimal treatment modality, frequency, and duration are yet to be defined and are perhaps reliant on individual patient attributes. Though unable to add to previous findings, we hope this review fosters interest in this potentially life-changing intervention in a primary healthcare context.

Downloads

Não há dados estatísticos.

Referências

Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011;378(9795):991-6.

World Health Organization. The top 10 causes of death [homepage]. Geneva: WHO; 2020 Dec 9 [cited 2021 Oct 21]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

World Health Organization. WHO methods and data sources for country-level causes of death: 2000-2019 [Internet]. Geneva: WHO; 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf

GBD Chronic Respiratory Diseases Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585-96.

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2022 report [Internet]. GOLD; 2022. Available from: https://goldcopd.org/wp-content/uploads/2021/12/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf

Tan WC, Sin DD, Bourbeau J, Hernandez P, Chapman KR, Cowie R, et al. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study. Thorax. 2015;70(9):822-9.

Divo MJ, Celli BR, Poblador-Plou B, Calderón-Larrañaga A, de-Torres JP, Gimeno-Feliu LA, et al. Chronic obstructive pulmonary disease (COPD) as a disease of early aging: evidence from the EpiChron Cohort. PLoS One. 2018;13(2):e0193143.

Viegi G, Maio S, Fasola S, Baldacci S. Global burden of chronic respiratory diseases. J Aerosol Med Pulmon Drug Deliv. 2020;33(4):171-7.

Fundação Portuguesa do Pulmão. ONDR 2020 [Internet]. Fundação Portuguesa do Pulmão; 2020. Available from: https://www.fundacaoportuguesadopulmao.org/ficheiros/ondr2020.pdf

Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980;93(3):391-8.

Mannino DM, Kiriz VA. Changing the burden of COPD mortality. Int J Chron Obstruct Pulmon Dis. 2006;1(3):219-33.

Wedzicha JA, Calverley PM, Albert RK, Anzueto A, Criner GJ, Hurst JR, et al. Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017;50(3):1602265.

Araujo ZT, Nogueira PA, Cabral EE, Santos LP, Silva IS, Ferreira GM. Effectiveness of low-intensity aquatic exercise on COPD: a randomized clinical trial. Respir Med. 2012;106(11):1535-43.

Theander K, Jakobsson P, Jörgensen N, Unosson M. Effects of pulmonary rehabilitation on fatigue, functional status and health perceptions in patients with chronic obstructive pulmonary disease: a randomized controlled trial. Clin Rehabil. 2009;23(2):125-36.

Behnke M, Taube C, Kirsten D, Lehnigk B, Jörres RA, Magnussen H. Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. Respir Med. 2000;94(12):1184-91.

Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary rehabilitation: joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131(5 Suppl):4S-42S.

Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-64.

Beauchamp MK, Janaudis-Ferreira T, Goldstein RS, Brooks D. Optimal duration of pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease: a systematic review. Chron Respir Dis. 2011;8(2):129-40.

Holland AE, Mahal A, Hill CJ, Lee AL, Burge AT, Cox NS, et al. Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial. Thorax. 2017;72(1):57-65.

Neves LF, Reis MH, Gonçalves TR. Home or community-based pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Cad Saude Publica. 2016;32(6):S0102-311X2016000602001.

Warren JR, Falster MO, Tran B, Jorm L. Association of continuity of primary care and statin adherence. PLoS One. 2015;10(10):e0140008.

Cox NS, Dal Corso S, Hansen H, McDonald CF, Hill CJ, Zanaboni P, et al. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013040.

Downloads

Publicado

2024-02-28

Como Citar

Oliveira, G., Félix, R., Ruivo dos Santos, P., ´Monteiro, L., & Tejo, C. (2024). Managing chronic obstructive pulmonary disease in primary health care: the impact of pulmonary rehabilitation. Revista Portuguesa De Medicina Geral E Familiar, 40(1), 58–67. https://doi.org/10.32385/rpmgf.v40i1.13749